Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT01965249
Other study ID # AAG-G-H-1308
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date February 2014
Est. completion date December 2024

Study information

Verified date July 2023
Source Aesculap AG
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The major long term complication of abdominal wall closure after a median laparotomy is the development of an incisional hernia. Several suture technique and suture material have been used but the incidence of this complication still lies between 9 -20%. Synthetic suture material which have become available over the last decades have the advantage that they are degraded by the body system and fully absorbed within 70-180 days; however they loss 50% of their initial strength already after 14-30 days and may not be the optimal suture material for abdominal wall closure. A new suture material (Monomax®) was developed with an extra-long absorption profile, high elasticity and with a superior initial strength. Therefore, the ESTOIH-Study was designed to investigate the influence of the stitch length on the occurrence of incisional hernia using the extra-long term absorbable, elastic, monofilament suture (Monomax®).


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 425
Est. completion date December 2024
Est. primary completion date December 15, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age =18 years - Patients undergoing an elective, primary median laparotomy with an incision length of = 15 cm - Expected survival time longer than 1 year - ASA I-III - Written informed consent Exclusion Criteria: - Emergency surgery - Patient undergoing surgery due to a pancreas carcinoma - Patients who will be operated due to an abdominal aortic aneurysm - Peritonitis - Coagulopathy - Current immunosuppressive therapy (more than 40 mg of a corticoid per day or azathioprin) - Chemotherapy within the last 2 weeks before operation - Radiotherapy of the abdomen within the last 6 weeks before operation - Pregnant women (pregnancy test has to be performed) - Severe neurologic and psychiatric disease - Lack of compliance

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Long stitch
AWC with the long stitch technique using MonoMax USP 1, 150 cm loop, HR48 mm
Short Stitch
Short stitch suture technique using MonoMax USP 2/0, 150 cm, HR26 mm

Locations

Country Name City State
Austria AKH Linz Linz
Austria Wilhelminenspital Wien Wien
Germany Vivantes Klinikum Spandau Berlin
Germany Städtisches Klinikum Braunschweig Braunschweig
Germany Klinikum der Johann-Wolfgang-Goethe Universität Frankfurt
Germany Klinik am Eichert, Allgemeinchirurgische Klinik Göppingen
Germany LMU Großhadern München
Germany Robert Bosch KH Stuttgart Stuttgart
Germany Klinikum Landkreis Tuttlingen, Klinik für Allgemein-, Viszeral, und Gefäßchirurgie Tuttlingen

Sponsors (2)

Lead Sponsor Collaborator
Aesculap AG B.Braun Surgical SA

Countries where clinical trial is conducted

Austria,  Germany, 

References & Publications (17)

Albertsmeier M, Hofmann A, Baumann P, Riedl S, Reisensohn C, Kewer JL, Hoelderle J, Shamiyeh A, Klugsberger B, Maier TD, Schumacher G, Kockerling F, Pession U, Weniger M, Fortelny RH. Effects of the short-stitch technique for midline abdominal closure: sh — View Citation

Albertsmeier M, Seiler CM, Fischer L, Baumann P, Husing J, Seidlmayer C, Franck A, Jauch KW, Knaebel HP, Buchler MW. Evaluation of the safety and efficacy of MonoMax(R) suture material for abdominal wall closure after primary midline laparotomy-a controlled prospective multicentre trial: ISSAAC [NCT005725079]. Langenbecks Arch Surg. 2012 Mar;397(3):363-71. doi: 10.1007/s00423-011-0884-6. Epub 2011 Dec 20. — View Citation

Diener MK, Voss S, Jensen K, Buchler MW, Seiler CM. Elective midline laparotomy closure: the INLINE systematic review and meta-analysis. Ann Surg. 2010 May;251(5):843-56. doi: 10.1097/SLA.0b013e3181d973e4. — View Citation

Fischer L, Baumann P, Husing J, Seidlmayer C, Albertsmeier M, Franck A, Luntz S, Seiler CM, Knaebel HP. A historically controlled, single-arm, multi-centre, prospective trial to evaluate the safety and efficacy of MonoMax suture material for abdominal wall closure after primary midline laparotomy. ISSAAC-Trial [NCT005725079]. BMC Surg. 2008 Jul 21;8:12. doi: 10.1186/1471-2482-8-12. — View Citation

Fortelny RH, Andrade D, Schirren M, Baumann P, Riedl S, Reisensohn C, Kewer JL, Hoelderle J, Shamiyeh A, Klugsberger B, Maier TD, Schumacher G, Kockerling F, Pession U, Hofmann A, Albertsmeier M. Effects of the short stitch technique for midline abdominal — View Citation

Fortelny RH, Baumann P, Thasler WE, Albertsmeier M, Riedl S, Steurer W, Kewer JL, Shamiyeh A. Effect of suture technique on the occurrence of incisional hernia after elective midline abdominal wall closure: study protocol for a randomized controlled trial. Trials. 2015 Feb 15;16:52. doi: 10.1186/s13063-015-0572-x. — View Citation

Harlaar JJ, Deerenberg EB, van Ramshorst GH, Lont HE, van der Borst EC, Schouten WR, Heisterkamp J, van Doorn HC, Cense HA, Berends F, Stockmann HB, Vrijland WW, Consten EC, Ottow RT, Go PM, Hermans JJ, Steyerberg EW, Lange JF. A multicenter randomized controlled trial evaluating the effect of small stitches on the incidence of incisional hernia in midline incisions. BMC Surg. 2011 Aug 26;11:20. doi: 10.1186/1471-2482-11-20. — View Citation

Hodgson NC, Malthaner RA, Ostbye T. The search for an ideal method of abdominal fascial closure: a meta-analysis. Ann Surg. 2000 Mar;231(3):436-42. doi: 10.1097/00000658-200003000-00018. — View Citation

Hsiao WC, Young KC, Wang ST, Lin PW. Incisional hernia after laparotomy: prospective randomized comparison between early-absorbable and late-absorbable suture materials. World J Surg. 2000 Jun;24(6):747-51; discussion 752. doi: 10.1007/s002689910120. — View Citation

Israelsson LA, Jonsson T, Knutsson A. Suture technique and wound healing in midline laparotomy incisions. Eur J Surg. 1996 Aug;162(8):605-9. — View Citation

Israelsson LA, Millbourn D. Closing midline abdominal incisions. Langenbecks Arch Surg. 2012 Dec;397(8):1201-7. doi: 10.1007/s00423-012-1019-4. Epub 2012 Nov 11. — View Citation

Miles JS. Use of polydioxanone absorbable monofilament sutures in orthopedic surgery. Orthopedics. 1986 Nov;9(11):1533-6. doi: 10.3928/0147-7447-19861101-09. — View Citation

Millbourn D, Cengiz Y, Israelsson LA. Effect of stitch length on wound complications after closure of midline incisions: a randomized controlled trial. Arch Surg. 2009 Nov;144(11):1056-9. doi: 10.1001/archsurg.2009.189. — View Citation

Millbourn D, Israelsson LA. Wound complications and stitch length. Hernia. 2004 Feb;8(1):39-41. doi: 10.1007/s10029-003-0159-4. Epub 2003 Sep 6. — View Citation

Seiler CM, Bruckner T, Diener MK, Papyan A, Golcher H, Seidlmayer C, Franck A, Kieser M, Buchler MW, Knaebel HP. Interrupted or continuous slowly absorbable sutures for closure of primary elective midline abdominal incisions: a multicenter randomized trial (INSECT: ISRCTN24023541). Ann Surg. 2009 Apr;249(4):576-82. doi: 10.1097/SLA.0b013e31819ec6c8. — View Citation

van 't Riet M, Steyerberg EW, Nellensteyn J, Bonjer HJ, Jeekel J. Meta-analysis of techniques for closure of midline abdominal incisions. Br J Surg. 2002 Nov;89(11):1350-6. doi: 10.1046/j.1365-2168.2002.02258.x. — View Citation

Weiland DE, Bay RC, Del Sordi S. Choosing the best abdominal closure by meta-analysis. Am J Surg. 1998 Dec;176(6):666-70. doi: 10.1016/s0002-9610(98)00277-3. — View Citation

* Note: There are 17 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Incisional hernia rate Incisional hernia rate 1 year postoperatively (assessment by ultrasound). 1 year postoperatively
Secondary Frequency of burst abdomen Burst abdomen is defined as a clinically evident rupture of the laparotomy wound participants will be followed for the duration of hospital stay, an expected average of 10 days
Secondary Reoperation due to burst abdomen Burst abdomen is defined as a clinically evident rupture of the laparotomy wound participants will be followed for the duration of hospital stay, an expected average of 10 days
Secondary Frequency of wound infections Wound infections are classified according to the US centres for disease control and prevention (CDC) as either deep or superficial. participants will be followed for the duration of hospital stay, an expected average of 10 days and 30 days postop
Secondary Wound healing complications Wound healing complications: Seroma, hematoma, necrosis, fistula until 30 days postoperatively
Secondary Long Term Incisional hernia rate assessment by ultrasound 3 and 5 years postoperatively
Secondary Long term Wound infections Wound infections are classified according to the US centres for disease control and prevention (CDC) as either deep or superficial. 1 year postoperatively
Secondary Long Term Wound healing complications Wound healing complications: Seroma, hematoma, necrosis, fistula until 1 year postoperatively
Secondary Costs Costs including material cost, cost per operation minute, cost per hospital stay, cost saving per incisional hernia. until 5 years postop
Secondary Length of postoperative hospital stay Number of days the patient has to stay in hospital after the intervention participants will be followed for the duration of hospital stay, an expected average of 10 days
Secondary Course of Health status with EQ-5D Score The EQ-5D-5L essentially consists of 2 pages: the EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS).
The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. Each answer results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions are combined into a 5-digit number that describes the patient's health state.
The EQ VAS records the patient's self-rated health on a vertical visual analogue scale, where the endpoints are labelled 'The best health you can imagine' and 'The worst health you can imagine'. The VAS can be used as a quantitative measure of health outcome that reflect the patient's own judgement.
preop, 30 days postop, 1 year, 3 years, 5 years postop